SparingVision to present new preclinical datas for Retintis Pigmentosa’s treatment during Annual Congress of the Association for Research in Vision and Ophthalmology ARVO


Journée Internationale des Maladies Rares – SparingVision lutte contre une maladie rare de la rétine: La rétinite pigmentaire


SparingVision Lauréate du Mercure des Entrepreneurs HEC 2019


The HEC Trajectory Award 2017 Spotlights Two Remarkable Women


SparingVision selected for public presentation at the 10th Annual Biotech Showcase in San Francisco


SparingVision sélectionnée pour une présentation publique au 10th Annual Biotech Showcase in San Francisco


SparingVision announces to be Winner and Grand Prix of the i-LAB 2017 French National Competition for Innovative Companies


The Foundation Fighting Blindness Clinical Research Institute (FFB-CRI), Bpifrance (Trough Biotechnology Accleration Fund & Innovative Biotherapies & Rare Diseases Fund set by the French national program « Investments for the future », and the Foundation Voir & Entendre (FVE) have invested in SparingVision: a total of € 15.5 million in SparingVIsion